Table 1.

Summary of Themes That Emerged From Disparity-Specific Comprehensive Cancer Control (CCC) Plans (N = 39), United States

Theme	No. of Plans	Definition	Jursidiction/CCC Plan Example
Participation	24	To increase the number or proportion of diverse participants in cancer clinical trials	District of Columbia: Increase the participation of eligible minority residents in cancer-related clinical trials by 15% by 2010
Education, awareness, and outreach	20	To provide general information about clinical trials to patients, the public, or other groups through various modes or channels	New Jersey: Educate the public regarding the purpose and importance of participating in clinical trials for cancer, with special emphasis on addressing the concerns of minority populations
Availability of trials	10	To increase the actual number or types of clinical trials for participation	New York: Increase the number of clinical trials focusing on cancer prevention and control in high-risk populations
Best practices	5	To use methods, processes, or techniques that are beneficial to diversifying clinical trial participation	Louisiana: Distribute information about the factors that have led to high clinical trial enrollment rates in an indigent, primarily African American population
Identifying barriers	5	To assess the specific factors that inhibit patients from participating in clinical trials	Arizona: Identify barriers that inhibit participation in clinical trials within minority populations
Partnerships and collaborations	5	To aim to develop relationships with organizations, institutions, or other groups	Oregon: Increase the enrollment of underserved populations in clinical trials by developing community-based partnerships that work with culturally diverse and underserved communities
Physician involvement	5	To engage physicians or providers as a strategy for educating or recruiting patients to clinical trials	California: Increase the awareness of community oncologists of the need for participation of diverse groups in clinical trials by encouraging those efforts in oncology associations
Financial support	4	To advocate for resources that aim to decrease the nonroutine costs associated with clinical trial participation for patients	Colorado: Develop interventions to alleviate the financial cost of participation in clinical trials studying treatment, supportive care, and quality of life for underserved and underinsured cancer patients
Funding	4	To advocate for broad-level resources to address nonroutine costs associated with clinical trial participation	New Mexico: Establish polices to ensure that funding is available for necessary follow-up care for those living in tribal communities who are screened for cancer through clinical trials and government-supported screening programs
Culturally appropriate information	3	To explicitly state the incorporation of culturally or linguistically specific information into the design or dissemination of clinical trials information	Indiana: Provide information about clinical trials in a culturally sensitive manner, including consent forms that are tailored to meet the patients' reading levels